About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Safety and Blood Level Study of Unit Dose Budesonide

NCT00627679·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Allergan

With

MAP Pharmaceuticals, Inc., a wholly owned subsidiary of Allergan
Q-Pharm Pty Limited

Age

18–50

Sex

ALL

Healthy volunteers

Accepted

You may be eligible if

Healthy adult volunteers, aged 18-50 years
BMI less than 30 kg/m2
Non smoker (currently and \<10 pack years total if ex-smoker)

You may not be if

Any use of corticosteroid in previous 4 weeks
Pregnancy/lactation
Significant blood donation (or testing) in previous 8 weeks

The record

StatusCompleted

PhasePhase 1

Taking part16

StartedDec 2005

UpdatedJan 9, 2014

Conditions

Where1

Q-Pharm Pty Limited
Brisbane, Queensland, Australia

Clareo Health | Safety and Blood Level Study of Unit Dose Budesonide